Puma Biotechnology
PBYI
PBYI
203 hedge funds and large institutions have $3.59B invested in Puma Biotechnology in 2017 Q4 according to their latest regulatory filings, with 53 funds opening new positions, 76 increasing their positions, 56 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
2.13% less ownership
Funds ownership: 98.59% → 96.46% (-2.1%)
18% less capital invested
Capital invested by funds: $4.39B → $3.59B (-$804M)
50% less funds holding in top 10
Funds holding in top 10: 12 → 6 (-6)
Holders
203
Holding in Top 10
6
Calls
$72.5M
Puts
$77.8M
Top Buyers
| 1 | +$244M | |
| 2 | +$84.8M | |
| 3 | +$56.4M | |
| 4 |
Wells Fargo
San Francisco,
California
|
+$46.1M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$44.7M |
Top Sellers
| 1 | -$324M | |
| 2 | -$78.8M | |
| 3 | -$57.9M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$40.1M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$33.2M |